REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
06/09/2025
Back to search
Official data from USPTO
GENE TRAFFIC CONTROL
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
GENE TRAFFIC CONTROL
ST13
US500000087839346Class
1, 5
Filing
87839346
Registration
6075464
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
36
Latest update
06/10/2025
Trademark type
Word
Nice classes
1, 5
Filing date
03/19/2018
Registration date
06/09/2020
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/09/2020
Last transaction
06/10/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
04/23/2019
First use in commerce
04/23/2019
Drawing code
4
Owner type
03
Owner location
Cambridge, MA
Examiner
VIGIL, JACOB
Law office
L30
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Foghorn Therapeutics, Inc.
Representatives
Christina M. Licursi WOLF, GREENFIELD & SACKS, P.C.
Technical classification
Nice Classes
Class 1Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Agents for scientific and research usepharmaceutical agents that modulate epigenetic mechanisms to treat disease for use in the field of biotechnology; chemical agents for use in the researchdiscovery and development of pharmaceuticals and research on epigenetic structures and functions; reagents for scientific and medical research use
Class 5
Agents for medical and veterinary usepharmaceutical preparations for the treatment of diseases and disordersoncologicalneurologicaldevelopmentalhematologicalbonerespiratorycentral nervous systemendrocrinologicalmetaboliccirculatorygastroenterologicalhormonal and diabetic disorders; pharmaceuticalsepigenetic modulating agents and chromatin regulating agents to treat disease; diagnostic agentspreparations and substances for medical purposes; diagnostic preparation platforms for medicinal use featuring epigenetic modulating agents and chromatin regulating agents to treat disease
Publications
History of USPTO decisions and trademark events.
36 publications found
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
05/20/2021
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
05/20/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
05/20/2021
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
05/20/2021
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
05/20/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
06/09/2020
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
05/06/2020
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
05/05/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/30/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/30/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
04/30/2020
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
11/08/2019
GNRT
NON-FINAL ACTION E-MAILED
11/08/2019
CNRT
SU - NON-FINAL ACTION - WRITTEN
11/08/2019
SUPC
STATEMENT OF USE PROCESSING COMPLETE
11/04/2019
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
11/01/2019
IUAF
USE AMENDMENT FILED
10/16/2019
EISU
TEAS STATEMENT OF USE RECEIVED
10/16/2019
DOCK
ASSIGNED TO EXAMINER
09/30/2019
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
04/22/2019
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
04/22/2019
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
04/16/2019
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
02/19/2019
PUBO
PUBLISHED FOR OPPOSITION
02/19/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01/30/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/13/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/07/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/07/2019
ALIE
ASSIGNED TO LIE
01/07/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/02/2019
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
07/05/2018
GNRT
NON-FINAL ACTION E-MAILED
07/05/2018
CNRT
NON-FINAL ACTION WRITTEN
07/05/2018
DOCK
ASSIGNED TO EXAMINER
06/28/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/24/2018
Continuous trademark protection
Get notified about every new filing that threatens GENE TRAFFIC CONTROL or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.